Events

ELRIG Research & Innovation 2025 takes place from 10–11 March at The Royal Society of Medicine in London, UK. The free-to-attend event will bring together scientists, researchers and entrepreneurs from across the drug discovery community working on proteins, RNA, cell and gene therapies, PROTACs, as well as the application of big data to support target identification, biomarkers and the development of big molecules. The two-day event will include sessions on: Big technology for big molecules, focussed on new and innovative technologies that are used for drug discovery and development of biotherapeutic drugs; Big molecules for big problems, exploring the innovative potential of large molecules in treating diseases and the hurdles in their development; and Big data for big insights: tran…

Embark on a transformative journey at the prestigious 8th Edition of the International Conference on Materials Science and Engineering, poised to take place in the enchanting city of Rome, Italy, and virtually from March 10 - 12, 2025, themed "Materials for Tomorrow: Advancements in Materials Science & Engineering" Esteemed scholars, researchers, academics, industry mavens, and enthusiasts from around the world are warmly invited to engage in this dynamic symposium, fostering interdisciplinary collaboration and the exchange of insights. Venture into the expansive realm of materials science and engineering, where innovation knows no bounds. Explore a diverse array of materials, from cutting-edge polymers to revolutionary biomaterials, each offering unique applications across various sec…

China’s Life Sciences Compliance webinar will discuss the regulatory structure and requirements for compliance against China’s NMPA regulations for Pharmaceuticals, Medical Devices, Biologics and Combination Products. Why Should You Attend: China has been improving its’ regulatory regime governing the food and pharmaceutical industry in recent years. By promulgating the amended GMP and amending GLP, GCP, GSP and other regulations, China will further align the country with international standards of practice. For manufacturers and distributors of drugs and medical devices in China, as well as importers, it will be important to pay close attention to the pace at which NMPA implements these changes. This course specifically focuses on the overall regulatory compliance requirements and procedu…

2024 has revitalized the bacteriophage field, with over $9 Million invested into BiomX and Locus Bioscience; $24 Million dedicated by BARDA to progress bacteriophage therapies to Phase II trials; and the release of further regulatory guidelines by agencies. The advancement to the clinic has resulted in a wealth of data available to investigate the function, genetic modification, and safety of bacteriophages. However, the lack of clarity on the pathway to the market with a sustainable and strategic commercial strategy means that biopharma companies need to rethink their business model to ensure they are sustainable. At the 7th Bacteriophage Therapy Summit, we'll be diving into the regulatory and investment landscape for drug developers, clinical updates showing efficacy, utilizing machine l…

8th Annual Pharma Regulatory 2025   “Recent regulatory developments – What’s the way forward?”   11th March 2025, Kohinoor Continental Hotel, Mumbai, India The 8th Annual Pharma Regulatory Summit 2025 brings together leading global pharmaceutical industry professionals and regulators to exchange insights on cutting-edge technologies, strategies, and solutions that drive innovation and uphold quality in medicines delivered to patients worldwide. This interactive forum features expert-led presentations and discussions, creating an ideal platform for professionals to explore and implement innovative solutions tailored to the evolving regulatory landscape of India’s pharmaceutical industry.   Please contact Email - kavitha@virtueinsight.co.in or Call - +91 44 24762472 / M: +91 9…

As the cell and gene therapy (CGT) pipeline matures and new, exciting technologies scale into the clinic, the success of delivering the growing number of complex CGTs to patients in a safe and timely manner relies on robust and resilient global supply chains. Join the 6th Supply Chain and Logistics for Cell and Gene Therapies Summit for the ultimate practical guide on designing and implementing scalable, traceable, and resilient global supply chains. For the first time, this forum will cover the full breadth of end-to-end supply chain challenges across both cell and gene therapy, bringing leading voices across autologous, allogeneic, in vivo, and ex vivo programs. Leading clinical and commercial drug developers, trusted service providers, and expert clinical sites will lend solution-led ca…

This webinar explains what actions should be taken following an unexpected positive result in a sterility test on a biological indicator (BI) during performance qualification or routine testing. It also addresses the actions to take when a test of sterility demonstrates unexpected growth during validation or routine dose audits. The various items that should be investigated to determine the root cause and the follow up to the investigation will be covered. Why Should You Attend: All sterile products require some level of sterility during validation and then during routine production. What actions your company takes when this testing exhibits results that do not meet expectations or specifications can be critical from a regulatory and safety standpoint. You nee…

700, MassBio, Technology Square, Middlesex County, 02139, United States

Join us at the MassBioHub in Cambridge, Massachusetts (USA) on March 12, 2025 for this exclusive complimentary event and expert panel discussion showcasing the impact of unified trial design and regulatory strategies on derisking and accelerating clinical development. Registration: From 11:30 am Panel discussion:12:00 Post discussion lunch: 12:45-13:30 Secure faster development and regulatory pathways Biotech organizations face a series of high-stakes decisions as they design their clinical development programs. These decisions include trade-offs between factors such as speed and cost, as well as delivery and regulatory risk. In this balancing act, too often, companies default to traditional study designs and endpoints, often missing opportunities for innovative approaches that c…

In 2025, the spotlight is on neurodegenerative drug development, driven by the triumph of Lecanemab and Donanemab, coupled with rapid advancements to enable presymptomatic diagnosis, reinvigorating the space with new targets, modalities, and technologies. Meanwhile significant advancements to target the likes of α-synuclein, NLRP3 and GBA suggest only a matter of time until a disease-modifying therapy emerges on the scene for Parkinson's too. Capitalizing on a new era of revitalized hope and momentum, the 13th Alzheimer's and Parkinson's Drug Development Summit returns as the only industry-focused and end-to-end meeting, with comprehensive coverage spanning early discovery through to late clinical, regulatory, and commercial development. Join industry's premier gathering of 150+ Alzheimer'…

Reuters Pharma USA 2025 will unite senior pharma leaders across commercial, marketing, medical affairs, patient engagement, market access, real world evidence and data for two days of learnings in Philadelphia. The 2025 agenda is streamed by priority - spotlighting use cases and tangible learnings across the key topic areas of customer engagement, tools and technology, value demonstration, and future proofing strategies. Outside of the conference rooms, attendees form connections through our hyper-interactive hackathons, workshops, roundtables, meet-and-eats, and our networking drinks reception. Don't hear about it after - be in the room. Time: 9:00 AM - 4:00 PM

We are thrilled to extend a warm welcome to the 18th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD 2025), scheduled to take place from 19-22 March, 2025, in Amsterdam, The Netherlands. We invite you to join us at ATTD, the premier international platform, where clinicians, diabetes care providers, researchers, industries, startups, investors, reimbursement authorities, regulators, and individuals living with diabetes convene with the shared aim of enhancing diabetes care at an accelerated pace. The conference will feature presentations and discussions led by esteemed professionals in the field, covering a diverse range of topics including artificial intelligence-driven decision support systems, glucose sensors, closed-loop systems, artificial pancreas t…

This webinar will focus on the Process for Quality Agreements and requirements that must be implemented to ensure compliance with the latest quality and regulatory requirements. Attendees will learn the reason for implementing a Quality Agreement system to assure adequate controls for Service Providers. Areas Covered in the Webinar: Regulatory Requirements for Quality Agreements Defining the Purpose of Quality Agreements Different Types of Quality Agreements with Service Providers Definition of Roles Between the Manufacturer and Service Providers Regulatory Roles in the Quality Agreement Expectations for Quality Agreements in Regulatory Inspections. Benefits of Quality Agreements from Both a Regulatory and Quality Perspective Enforcement of Quality Agreements Monitoring of Agreements. Wh…

This webinar addresses the Computer Software Assurance guidance related to 21 CFR Part 11, and the European equivalent Annex 11 for local, and SaaS/Cloud hosted applications. It details the evolution of industry practices that increase productivity and ensure compliance. Learn the latest validation models and fill-in-the-blank templates. Learning Objectives: Which data and systems are subject to Part 11 and Annex 11 Computer Software Assurance impact on risk-based Impact of Electronic Systems… Clinical Investigations Q&A Guidance for Industry Oct 2024 Avoid 483 and Warning Letters Requirements for local, SaaS, and cloud hosting Reduce validation resources by using easy to understand fill-in-the-blank validation documents Areas Covered in the Webinar: What 21 CFR Part 11 means t…

Over the past year, the Treg sector has seen groundbreaking investments and strategic collaborations between leading biotech and pharma companies like Quell and AstraZeneca, and Parvus and AbbVie, creating a surge of innovation and spotlighting Treg cell therapies and modulators as the next frontier in autoimmune and inflammatory disease treatments. Tregs hold the potential to revolutionize care for conditions that have long lacked effective solutions and are the future of precision medicine in autoimmune and inflammatory diseases.   Date and Time: Tuesday, 25 March 2025 at 08:00 to Thursday, 27 March 2025 at 17:00

Welcome to the 8th Gene Therapy Development Summit Transforming the Future of Gene Therapies for Rare and Common Diseases With 14 new gene therapy approvals in the last 18 months, billion-dollar collaborations, and the development of treatments for more common conditions, the gene therapy field is rapidly gaining momentum and broadening scope beyond rare diseases. Returning to Boston in March, the 8th Gene Therapy Development Summit, formerly known as the Gene Therapy for Rare Disorders Summit, will unite 200+ gene therapy experts to tackle the field's biggest challenges of achieving genuine scalability and accessibility to meet growing patient demand. For the first time, this industry-defining meeting will reflect the field's growing focus on developing therapies for common diseases, whil…

The Biotech Roadshow: Shaping the Future of Clinical Trials with Expert Insights will take place in person on Tuesday, 25th March at Alderley Park, Macclesfield, UK from 10 am to 2 pm. This face-to-face event is a unique opportunity to engage directly with expert industry leaders and peers. Phastar experts will be on hand to answer your most pressing questions and discuss the challenges you’re facing in clinical trials and offer tailored solutions. Talks will include: Early Phase Clinical Trials: Key Considerations for Drug Development Pipelines with Q & A Harnessing Bayesian Methods: Tackling Challenges in Rare Disease and Small Population Trials  Leveraging Real-World Evidence: Data Sources, Challenges, and Applications in Modern Clinical Tria…